Next Article in Journal
Cancer Stem Cells, Bone and Tumor Microenvironment: Key Players in Bone Metastases
Next Article in Special Issue
Respiratory-Gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers
Previous Article in Journal
Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer
Previous Article in Special Issue
Clinical Implementation of Robust Optimization for Craniospinal Irradiation
Open AccessFeature PaperArticle

Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability

1
Department of Radiation Oncology (MAASTRO), GROW—School for Oncology and Developmental Biology, Maastricht University Medical Centre, Doctor Tanslaan 12, Maastricht 6229 ET, The Netherlands
2
The D‐Lab: Decision Support for Precision Medicine, GROW—School for Oncology and Developmental Biology, Maastricht University Medical Centre, Universiteitssingel 40, Maastricht 6229 ER, The Netherlands
3
Gray Laboratory, CRUK/MRC Oxford Oncology Institute, University of Oxford, ORCRB-Roosevelt Drive, Oxford OX3 7DQ, UK
4
Department of Radiation Oncology and Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Medical University of Vienna, 1090 Vienna, Austria
5
Gray Laboratory, CRUK/MRC Oxford Oncology Institute, The University of Oxford, ORCRB-Roosevelt Drive, Oxford OX3 7DQ, UK
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(2), 55; https://doi.org/10.3390/cancers10020055
Received: 27 November 2017 / Revised: 19 January 2018 / Accepted: 14 February 2018 / Published: 18 February 2018
(This article belongs to the Special Issue Proton and Carbon Ion Therapy)
We present a methodology which can be utilized to select proton or photon radiotherapy in prostate cancer patients. Four state-of-the-art competing treatment modalities were compared (by way of an in silico trial) for a cohort of 25 prostate cancer patients, with and without correction strategies for prostate displacements. Metrics measured from clinical image guidance systems were used. Three correction strategies were investigated; no-correction, extended-no-action-limit, and online-correction. Clinical efficacy was estimated via radiobiological models incorporating robustness (how probable a given treatment plan was delivered) and stability (the consistency between the probable best and worst delivered treatments at the 95% confidence limit). The results obtained at the cohort level enabled the determination of a threshold for likely clinical benefit at the individual level. Depending on the imaging system and correction strategy; 24%, 32% and 44% of patients were identified as suitable candidates for proton therapy. For the constraints of this study: Intensity-modulated proton therapy with online-correction was on average the most effective modality. Irrespective of the imaging system, each treatment modality is similar in terms of robustness, with and without the correction strategies. Conversely, there is substantial variation in stability between the treatment modalities, which is greatly reduced by correction strategies. This study provides a ‘proof-of-concept’ methodology to enable the prospective identification of individual patients that will most likely (above a certain threshold) benefit from proton therapy. View Full-Text
Keywords: prostate cancer; radiotherapy; proton therapy; clinical decision support systems; in silico trial; radiobiological modelling prostate cancer; radiotherapy; proton therapy; clinical decision support systems; in silico trial; radiobiological modelling
Show Figures

Graphical abstract

MDPI and ACS Style

Walsh, S.; Roelofs, E.; Kuess, P.; Van Wijk, Y.; Vanneste, B.; Dekker, A.; Lambin, P.; Jones, B.; Georg, D.; Verhaegen, F. Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability. Cancers 2018, 10, 55.

AMA Style

Walsh S, Roelofs E, Kuess P, Van Wijk Y, Vanneste B, Dekker A, Lambin P, Jones B, Georg D, Verhaegen F. Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability. Cancers. 2018; 10(2):55.

Chicago/Turabian Style

Walsh, Seán; Roelofs, Erik; Kuess, Peter; Van Wijk, Yvonka; Vanneste, Ben; Dekker, Andre; Lambin, Philippe; Jones, Bleddyn; Georg, Dietmar; Verhaegen, Frank. 2018. "Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability" Cancers 10, no. 2: 55.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop